JP6263815B2 - 細胞死抑制剤及びその製造方法 - Google Patents

細胞死抑制剤及びその製造方法 Download PDF

Info

Publication number
JP6263815B2
JP6263815B2 JP2015504347A JP2015504347A JP6263815B2 JP 6263815 B2 JP6263815 B2 JP 6263815B2 JP 2015504347 A JP2015504347 A JP 2015504347A JP 2015504347 A JP2015504347 A JP 2015504347A JP 6263815 B2 JP6263815 B2 JP 6263815B2
Authority
JP
Japan
Prior art keywords
group
compound
formula
carbon atoms
cell death
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015504347A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2014136808A1 (ja
Inventor
あやの 佐藤
あやの 佐藤
勇太 仁科
勇太 仁科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Okayama University NUC
Original Assignee
Okayama University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okayama University NUC filed Critical Okayama University NUC
Publication of JPWO2014136808A1 publication Critical patent/JPWO2014136808A1/ja
Application granted granted Critical
Publication of JP6263815B2 publication Critical patent/JP6263815B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2015504347A 2013-03-05 2014-03-05 細胞死抑制剤及びその製造方法 Expired - Fee Related JP6263815B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2013043562 2013-03-05
JP2013043563 2013-03-05
JP2013043562 2013-03-05
JP2013043563 2013-03-05
PCT/JP2014/055533 WO2014136808A1 (fr) 2013-03-05 2014-03-05 Inhibiteur de la mort cellulaire, et son procédé de production

Publications (2)

Publication Number Publication Date
JPWO2014136808A1 JPWO2014136808A1 (ja) 2017-02-16
JP6263815B2 true JP6263815B2 (ja) 2018-01-24

Family

ID=51491320

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015504346A Expired - Fee Related JP6263814B2 (ja) 2013-03-05 2014-03-05 細胞死抑制剤及び新規化合物
JP2015504347A Expired - Fee Related JP6263815B2 (ja) 2013-03-05 2014-03-05 細胞死抑制剤及びその製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015504346A Expired - Fee Related JP6263814B2 (ja) 2013-03-05 2014-03-05 細胞死抑制剤及び新規化合物

Country Status (2)

Country Link
JP (2) JP6263814B2 (fr)
WO (2) WO2014136808A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120863A (en) * 1977-09-27 1978-10-17 The United States Of America As Represented By The Secretary Of The Air Force Fluorine-containing benzoxazoles
WO2001074807A1 (fr) * 2000-03-30 2001-10-11 Sagami Chemical Research Center Derives indolylpyrrole et inhibiteurs de mort cellulaire

Also Published As

Publication number Publication date
WO2014136808A1 (fr) 2014-09-12
JP6263814B2 (ja) 2018-01-24
JPWO2014136807A1 (ja) 2017-02-16
JPWO2014136808A1 (ja) 2017-02-16
WO2014136807A1 (fr) 2014-09-12

Similar Documents

Publication Publication Date Title
AU2011281421A1 (en) Process for preparing aminobenzoylbenzofuran derivatives
CN110204486B (zh) 一种喹啉衍生物的合成方法
JP2010037289A (ja) ３官能ニトリルオキシドおよびその製造方法
CA2971093A1 (fr) Procede de preparation de cenicriviroc et d'analogues apparentes
EP3088391B1 (fr) Procédé de production de dérivé d'ester 2-aminonicotinate de benzyle
JP6263815B2 (ja) 細胞死抑制剤及びその製造方法
CA3011662A1 (fr) Procede ameliore pour la preparation de regorafenib
US10640465B2 (en) Method for preparing phenylalanine compound
WO2012174685A1 (fr) Procédé de préparation d'un dérivé de 2h-1,2,3-triazole 2-substitué
JP2016198736A (ja) アミノサリチルアルジミン配位子を金属に配位させた触媒及びこれを用いたヨード環化体の製造方法
JP4219696B2 (ja) 光学活性トランス−１，２−シクロヘキサンジカルボン酸誘導体の製造方法
TWI687418B (zh) 唑苯衍生物之結晶
JP2007153823A (ja) アレンカルボン酸エステル類の製造法
CN105669596B (zh) 一种n,n‑二烷基胺基酚的制备方法
RU2701515C2 (ru) Производное азолобензола и его кристаллическая форма
CN111556861A (zh) 茉莉酸酯化合物的制备方法
JP5702956B2 (ja) 芳香族トリカルボン酸
WO2014157021A1 (fr) Procédé de fabrication de composé pyridazinone
JP6856365B2 (ja) アジルサルタンの製造方法
JP2015174853A (ja) ２−（４−メチル−２−フェニルピペラジン−１−イル）ピリジン−３−メタノールの製造方法
JP2010037288A (ja) ３官能ニトリルオキシドおよびその製造方法
KR20100067886A (ko) (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
CN109553544B (zh) 一种双氯芬酸钠的合成方法
CN104961670B (zh) 一种n,o‑双取代的酮亚胺衍生物的制备方法
EP3406595B1 (fr) Procédé de production de dérivé d'ester benzylique d'acide 2-aminonicotinique

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20171114

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171201

R150 Certificate of patent or registration of utility model

Ref document number: 6263815

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees